Skip to Main Content
Contribute Try STAT+ Today

Good morning. Happy Wednesday. This is Kate Sheridan, filling in for Ed Silverman this morning from STAT’s thriving bureau in Queens, where the official mascots are cats. Today’s cup of stimulation is made with store-brand French roast beans ground in a blender because I mistakenly grabbed a large bag of whole beans instead of my usual ground coffee. Best served black with a hint of chagrin. Ed will be back tomorrow, no doubt with better coffee. Until then, here’s today’s news. …

Theranos founder Elizabeth Holmes goes on trial in federal court on Wednesday, with prosecutors poised to lay out fraud charges against the former Silicon Valley star accused of lying about her now-defunct blood-testing startup once valued at $9 billion, Reuters reports. Holmes faces 10 counts of wire fraud and is expected to testify. The trial could take about four months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment